The MTS assay and colony forming assays showed that USP22 silencing significantly inhibited the cell proliferation ability of pancreatic cancer cells, which could be reversed by PTEN overexpression (Fig. 2H,I). This evidence concerns the gene USP22 and familial pancreatic carcinoma.